En Hu

机构：Fujian Medical University, Scripps Health, Mengchao Hepatobiliary Hospital, Austin Health, University of New England · ORCID：0000-0002-1000-7260

发表论文 29 篇 · 总被引 421 次 · h-index 7

代表论文

• Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma (2023 · Nature Communications · 被引 92)
• Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy (2023 · Cell Reports Medicine · 被引 48)
• RNA Methyltransferase FTSJ3 Regulates the Type I Interferon Pathway to Promote Hepatocellular Carcinoma Immune Evasion (2023 · Cancer Research · 被引 22)
• Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma (2021 · Cancer Science · 被引 20)
• Proteomic Analysis Identifies GSN as a Noninvasive Circulating Serum Biomarker for Predicting Early Recurrence of Hepatocellular Carcinoma (2024 · Journal of Proteome Research · 被引 6)
• The prognostic nutritional index as a predictor of efficacy and early recurrence for adjuvant transarterial chemoembolization in hepatocellular carcinoma (2024 · Clinics and Research in Hepatology and Gastroenterology · 被引 4)